Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 183

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 6
Chunk 183
---
met market needs. Prof. Tam’s research projects
over the past twenty years has crossed subjects, disciplines and methodologies, yet the main research interests remain focused on the
different pathophysiological aspects of the endocannabinoid system. Having a clinical background with basic science training, he has always
been interested in how science can directly improve people’s everyday lives. Thus, he has strived unceasingly to integrate his clinical
curiosity and experimental knowledge, in order to deepen the understanding of clinically relevant research questions.

Fatima Cody Stanford, MD, MPH, MPA, is currently
associated with Massachusetts General Hospital and is an Associate Professor of Medicine and Pediatrics at Harvard Medical School, where
she serves as an educator, researcher, and policy maker. Her extensive academic background includes a Bachelor of Science and Master of
Public Health from Emory University, a MD from the Medical College of Georgia School of Medicine, a Masters of Public Administration from
the Harvard Kennedy School of Government and a MBA from the Quantic School of Business and Technology. Dr. Stanford completed her Obesity
Medicine & Nutrition Fellowship at Massachusetts General Hospital and Harvard Medical School, further enhancing her expertise in the
field. With a career dedicated to bridging the gaps between medicine, public health, and policy, Dr. Stanford has become a sought-after
expert in obesity medicine, both nationally and internationally.

Prof. Henry R. Kranzler, MD, PhD, is the
Benjamin Rush Professor of Psychiatry, and Director of the Center for Studies of Addiction, at the University of Pennsylvania’s
Perelman School of Medicine. His research focuses on the genetics and pharmacological treatment of substance dependence, with emphasis
on precision addiction medicine. His research has been continuously supported since 1987 by grants from the National Institutes of Health.
Professor Kranzler has authored or co-authored more than 600 journal articles, book chapters, and books, is a member of the editorial
board of three peer-review journals as well as the editor of Alcohol: Clinical and Experimental Research. His work currently focuses on
the molecular genetics of substance dependence and the personalized treatment of alcohol, opioid, and nicotine use disorders using a pharmacogenetic
approach.

Arrangements for Election of Directors and Members of Management

There are no arrangements or understandings with
major shareholders, customers, suppliers or others pursuant to which any of our executive management or our directors were selected. See
“ Item 7. B. Related Party Transactions” for additional information.

B.